Mirum Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.52B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is ap...